GRANT. Professor Henrik Zetterberg at the University of Gothenburg will head a major European research collaboration, which is developing a significantly easier way to diagnose Alzheimer’s disease at an early stage through a blood test. Such a test could offer the potential for developing new treatments for Alzheimer’s and related dementias. . Through its Diagnostics Accelerator, the Alzheimer’s Drug Discovery Foundation (ADDF) – a U.S. based non-profit – is committed…
Alzheimer’s and amyloid brain plaques: New insights
STUDY. The Analytical Neurochemistry research group in Mölndal recently published a study detailing chemical changes in the deposits of the protein beta-amyloid in the brain. This protein is characteristic of Alzheimer’s disease. Alzheimer’s disease is very common in older people — one in eight aged over 65 suffer from it. Despite intensive research all over the world, the exact mechanism behind the disease remains unknown. The most characteristic feature of…
Alzheimer’s Disease revealed in blood test long before clinical symptoms occur
NEW STUDY. Research conducted by Dr. Nicholas Ashton, University of Gothenburg and MedTech West, has added further evidence in the possible utility of a blood test for predicting Alzheimer’s disease (AD). Using a mass spectrometry technique, the results show that a particular profile of proteins in blood was very accurate in predicting individuals with AD pathology in brain even before any clinical symptoms were present. While there is currently no…
Silke Kern wants to know how early signs of Alzheimer`s disease lead to Alzheimer’s dementia
RESEARCH. Alzheimer’s disease is a protracted process. It can take 15 years or more from the first molecular signs indicating that something has changed in the brain until dementia symptoms occur. Silke Kern, who recently was appointed to a high clinical ALF medical position, is examining what’s happening in the brain from the earliest changes that can be measured in cerebrospinal fluid until the patient later develops dementia. The world’s…
Berzelius silver medal to Jörg Hanrieder
AWARD. Jörg Hanrieder, Associate Professor at the section of psychiatry and neurochemistry, has been awarded this year’s silver Berzelius medal. He receives this award for his work in neuroproteomics, in particular for his development of novel tools for imaging mass spectrometry. This year’s Berzelius medals were handed out in Stockholm in late August, during the Euroanalysis conference, which this year attracted approximately 500 participants from 30 countries. “Of course it…